Author(s):
Hetvi Patel, Rupalben Jani, Nidhi Patel
Email(s):
rupal.jani@paruluniversity.ac.in
DOI:
10.52711/0974-360X.2024.00540 
Address:
Hetvi Patel1*, Rupalben Jani2, Nidhi Patel1
1Faculty of Pharmacy, Department of Pharmaceutics, Parul Institute of Pharmacy and Research, Parul University, Waghodia, Vadodara – 391760.
2Parul Institute of Pharmaceutical Education and Research, Parul University,Waghodia, Vadodara – 391760.
*Corresponding Author
Published In:
Volume - 17,
Issue - 7,
Year - 2024
ABSTRACT:
Rosacea is a long-term, chronic inflammatory skin disorder characterised by remissive episodes. It usually affects your central face with the symptoms of redness, inflammation, visible blood vessels, swollen bumps and enlarged nose. Approximately 415 million people worldwide suffer from rosacea. Conventional topical treatments such as gels, ointments, creams and lotions have demonstrated limited effectiveness due to skin’s natural barrier nature, which hinders the penetration of active ingredients. To overcome these problems novel drug delivery systems has been developed. These systems have the ability to enhance drug's efficacy by increasing their penetration across stratum corneum also these systems provide sustain and controlled drug release at targeted sites thus prevent the side effects of the drug. This article offers necessary details regarding rosacea like its types, etiology, diagnosis along with the novel therapies which is being used for the treatment of rosacea. Future prospects for the treatment of rosacea are also covered.
Cite this article:
Hetvi Patel, Rupalben Jani, Nidhi Patel. Revolutionizing Rosacea Treatment with Novel Drug Delivery Systems: A Review. Research Journal of Pharmacy and Technology. 2024; 17(7):3452-8. doi: 10.52711/0974-360X.2024.00540
Cite(Electronic):
Hetvi Patel, Rupalben Jani, Nidhi Patel. Revolutionizing Rosacea Treatment with Novel Drug Delivery Systems: A Review. Research Journal of Pharmacy and Technology. 2024; 17(7):3452-8. doi: 10.52711/0974-360X.2024.00540 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-7-73
REFERENCES:
1. Chien YW. Novel drug delivery systems. Drugs and The Pharmaceutical Sciences. 1992; 50.
2. McElnay JC, Hughes CM. Drug delivery: buccal route. Encyclopedia of Pharmaceutical Technology. 2002; 1: 800-10.
3. Balamurugan M, Saravanan VS, Ganesh P, Senthil SP, Hemalatha PV, Sudhir Pandya. Development and In-vitro Evaluation of Mucoadhesive Buccal Tablets of Domperidone. Research J. Pharm. and Tech. 2008; 1(4): 377-380. doi.org/10.5958/0974-360X
4. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Advanced Drug Delivery Reviews. 2005; Nov 3; 57(11): 1666-91. https://doi.org/10.1016/j.addr.2005.07.003
5. Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci. 1998; Jan 1; 1(1): 15-30. PMID: 10942969.
6. Rajashree S Masareddy, Mac R Kella, Amol B Kokate, Kiran Suryadevara. Buccal Mucosa as a Site for Drug Delivery. Research J. Pharm. and Tech. 2010; 3(3): 676-681. doi.org/10.5958/0974-360X
7. Bruschi ML, de Freitas O. Oral bioadhesive drug delivery systems. Drug Development and Industrial Pharmacy. 2005; Jan 1; 31(3): 293-310.https://doi.org/10.1081/DDC-52073
8. Chowdary KP, Rao YS. Mucoadhesive microspheres for controlled drug delivery. Biological and Pharmaceutical Bulletin. 2004; 27(11): 1717-24. doi.org/10.1248/bpb.27.1717
9. HaGerstrom H, Edsman K, Strømme M. Low-frequency dielectric spectroscopy as a tool for studying the compatibility between pharmaceutical gels and mucous tissue. Journal of Pharmaceutical Sciences. 2003; Sep 1; 92(9): 1869-81. doi.org/10.1002/jps.10451
10. Chaturvedi M, Kumar M, Pathak K. A review on mucoadhesive polymer used in nasal drug delivery system. Journal of Advanced Pharmaceutical Technology & Research. 2011; 2(4): 215. doi.org/10.4103/2231-4040.90876
11. Jain N, Gulat N, Kumar D, Nagaich U. Microspheres: mucoadhesion based controlled drug delivery system. RGUHS J Pharm Sci. 2012; 2(3): 28-40. doi.org/10.1248/bpb.27.1717
12. Shaikh R, Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. Journal of pharmacy and Bioallied Sciences. 2011; Jan; 3. doi.org/10.4103/0975-7406.76478
13. Dr. Y. Krishna Reddy, JuveriaTasleem. Formulation and Evaluation of Bioadhesive Buccal Drug Delivery of Sumatriptan Succinate Tablets. Asian J. Pharm. Res. 2020; 10(2). doi.org/105-10910.5958/2231-5691.2020.00020.9
14. Rossi S, Sandri G, Caramella CM. Buccal drug delivery: a challenge already won?. Drug Discovery Today: Technologies. 2005; Mar 1; 2(1):59-65. doi.org/10.1016/j.ddtec.2005.05.018
15. Hao J, Heng PW. Buccal delivery systems. Drug development and Industrial Pharmacy. 2003; Jan 1; 29(8): 821-32. doi.org/10.1081/ddc-120024178
16. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. Journal of Controlled Release. 2006; Aug 10; 114(1): 15-40. doi.org/10.1016/j.jconrel.2006.04.012.
17. Adhikari SN, Nayak BS, Nayak AK, Mohanty B. Formulation and evaluation of buccal patches for delivery of atenolol. Aaps Pharmscitech. 2010; Sep; 11(3): 1038-44. doi.org:10.1208/s12249-010-9459-z
18. Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. Journal of controlled release. 2011; Jul 30; 153(2): 106-16. doi.org/10.1016/j.jconrel.2011.01.027
19. Venkatalakshmi R, Sudhakar Y, Chetty MC, Sasikala C, Varma MM. Buccal drug delivery using adhesive polymeric patches. International Journal of Pharmaceutical Sciences and Research. 2012; Jan 1; 3(1): 35.http://dx.doi.org/10.13040/IJPSR.0975-8232.3(1).35-41
20. Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian Journal of Pharmaceutical Sciences. 2008; Jan; 70(1): 43. doi.org/10.4103/0250-474X.40330
21. Ahmed MG, Charyulu RN, Harish NM, Prabhu P. Formulation and in-vitro evaluation of Chitosan films containing tetracycline for the treatment of periodontitis. Asian Journal of Pharmaceutics (AJP). 2009; 3(2). https://doi.org/10.22377/ajp.v3i2.251
22. Nafee NA, Boraie MA, Ismail FA, Mortada LM. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharmaceutica (Zagreb, Croatia). 2003; Sep 1; 53(3): 199-212: PMID/14769243
23. Kevin C Garala, Romal J Garala, Harinath N More, Anil J Shinde. Effect of Cross-linking Agent on the Release of Drug from the Transdermal Matrix Patches of Tramadol Hydrochloride. Research J. Pharm. and Tech. 2008; 1(3): July-Sept. 187-192. doi.org/10.5958/0974-360X
24. Sahni J, Raj S, Ahmad FJ, Khar RK. Design and in vitro characterization of buccoadhesive drug delivery system of insulin. Indian Journal of Pharmaceutical Sciences. 2008; Jan; 70(1): 61. doi.org/ 10.4103/0250-474X.40333
25. Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M, Rossi C. Development of mucoadhesive patches for buccal administration of ibuprofen. Journal of Controlled Release. 2004; Sep 14; 99(1): 73-82. doi.org/10.1016/j.jconrel.2004.06.005
26. Doijad RC, Manvi FV, Rao VM, Patel PS. Buccoadhesive drug delivery system of isosorbide dinitrate: Formulation and evaluation. Indian Journal of Pharmaceutical Sciences. 2006; 68(6): 744. doi.org/10.4103/0250-474X.31007
27. Pendekal MS, Tegginamat PK. Formulation and evaluation of a bioadhesive patch for buccal delivery of tizanidine. Acta Pharmaceutica Sinica B. 2012; Jun 1; 2(3): 318-24. doi.org/10.1016/j.apsb.2011.12.012
28. Aswathy Bose, Shajan Abraham, Steffy P Raju, Nisha Ullas, Chippy S Pillai, Elessy Abraham, Dibyalochan Mohanty. Formulation and evaluation of sitagliptin buccal patch. Research J. Pharm. and Tech. 2020; 13(10): 4883-4887. doi.org/10.5958/0974-360X.2020.00859.8
29. Wani MS, Dehghan MH, Mahendrakumar C, Polshettiwar SA, Yadav VB.Design and Evaluation of Terbutaline Sulphate Buccal Patch. Research J. Pharm. and Tech. 2009; 2(1): 86-90. doi.org/10.5958/0974-360X